AwesomeCapital
Search This Blog
Thursday, June 18, 2026
Biogen to acquire private immunology biotech RayThera for up to $1B
Biogen to acquire private immunology biotech RayThera for up to $1 billion
Deal adds multiple early-stage anti-inflammatory assets from
RayThera Inc.
to
Biogen's immunology and inflammation pipeline
.
https://finviz.com/stock?t=BIIB&p=d
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.